» Articles » PMID: 16353963

Formulation and Evaluation of Mucoadhesive Glipizide Microspheres

Overview
Publisher Springer
Specialty Pharmacology
Date 2005 Dec 16
PMID 16353963
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this research was to formulate and systematically evaluate in vitro and in vivo performances of mucoadhesive microspheres of glipizide. Glipizide microspheres containing chitosan were prepared by simple emulsification phase separation technique using glutaraldehyde as a cross-linking agent. Results of preliminary trials indicate that volume of cross-linking agent, time for cross-linking, polymer-to-drug ratio, and speed of rotation affected characteristics of microspheres. Microspheres were discrete, spherical, and free flowing. The microspheres exhibited good mucoadhesive property in the in vitro wash-off test and also showed a high percentage drug entrapment efficiency. A 3(2) full factorial design was employed to study the effect of independent variables, polymer-to-drug ratio (X(1) ), and stirring speed (X(2) ) on dependent variables percentage mucoadhesion, t(80), drug entrapment efficiency, and swelling index. The best batch exhibited a high drug entrapment efficiency of 75% and a swelling index of 1.42; percentage mucoadhesion after 1 hour was 78%. The drug release was also sustained for more than 12 hours. The polymer-to-drug ratio had a more significant effect on the dependent variables. In vivo testing of the mucoadhesive microspheres to albino Wistar rats demonstrated significant hypoglycemic effect of glipizide.

Citing Articles

Amphiphilic, lauric acid-coupled pluronic-based nano-micellar system for efficient glipizide delivery.

Kumar V, Poonia N, Kumar P, Verma P, Alshammari A, Albekairi N Saudi Pharm J. 2024; 32(5):102046.

PMID: 38577487 PMC: 10992704. DOI: 10.1016/j.jsps.2024.102046.


Utilization of a nanostructured lipid carrier encapsulating pitavastatin- oil for enhancing cytotoxicity against the gingival carcinoma HGF-1 cell line.

Felimban R, Tayeb H, Chaudhary A, Felemban M, Alnadwi F, Ali S Drug Deliv. 2022; 30(1):83-96.

PMID: 36510636 PMC: 9754020. DOI: 10.1080/10717544.2022.2155269.


Development and Optimization of Acriflavine-Loaded Polycaprolactone Nanoparticles Using Box-Behnken Design for Burn Wound Healing Applications.

Nawaz T, Iqbal M, Khan B, Nawaz A, Hussain T, Hosny K Polymers (Basel). 2022; 14(1).

PMID: 35012125 PMC: 8747314. DOI: 10.3390/polym14010101.


Palmitic Acid-Pluronic F127-Palmitic Acid Pentablock Copolymer as a Novel Nanocarrier for Oral Delivery of Glipizide.

Kamboj V, Verma P Turk J Pharm Sci. 2020; 16(3):265-272.

PMID: 32454724 PMC: 7227949. DOI: 10.4274/tjps.galenos.2018.20082.


Preparation, Optimization and In vitro Evaluation of Glipizide Nanoparticles Integrated with Eudragit RS-100.

Saharan P, Bahmani K, Saharan S Pharm Nanotechnol. 2019; 7(1):72-85.

PMID: 30892168 PMC: 6691851. DOI: 10.2174/2211738507666190319124513.


References
1.
Lee J, Park J, Robinson J . Bioadhesive-based dosage forms: the next generation. J Pharm Sci. 2000; 89(7):850-66. DOI: 10.1002/1520-6017(200007)89:7<850::AID-JPS2>3.0.CO;2-G. View

2.
Thombre A, DeNoto A, Gibbes D . Delivery of glipizide from asymmetric membrane capsules using encapsulated excipients. J Control Release. 1999; 60(2-3):333-41. DOI: 10.1016/s0168-3659(99)00086-3. View

3.
Woo B, Jiang G, Jo Y, Deluca P . Preparation and characterization of a composite PLGA and poly(acryloyl hydroxyethyl starch) microsphere system for protein delivery. Pharm Res. 2002; 18(11):1600-6. DOI: 10.1023/a:1013090700443. View

4.
El-Gibaly I . Development and in vitro evaluation of novel floating chitosan microcapsules for oral use: comparison with non-floating chitosan microspheres. Int J Pharm. 2002; 249(1-2):7-21. DOI: 10.1016/s0378-5173(02)00396-4. View

5.
Vasir J, Tambwekar K, Garg S . Bioadhesive microspheres as a controlled drug delivery system. Int J Pharm. 2003; 255(1-2):13-32. DOI: 10.1016/s0378-5173(03)00087-5. View